Browsing "1. Journal Papers" by Identifier
Showing results 5941 to 6000 of 7085
-
OAK-9999-20031
1
-
OAK-9999-20032
1
-
OAK-9999-20141
1
-
ONCOLOGY REPORTS, Vol.4(4) : 791-794, 1997
1
-
ONCOTARGET , Vol.6(31) : 31018-31029, 2015
1
-
ONCOTARGET , Vol.7(18) : 24962-24982, 2016
1
-
ONCOTARGET , Vol.7(23) : 33765-33782, 2016
1
-
ONCOTARGET , Vol.7(27) : 41718-41810, 2016
1
-
ONCOTARGET , Vol.8(12) : 19947-19967, 2017
1
-
ONCOTARGET , Vol.8(45) : 78781-78795, 2017
1
-
ONCOTARGET, Vol.8(46) : 80325-80335, 2017
1
-
OPTICS COMMUNICATIONS , Vol.422 : 64-68, 2018
1
-
OPTICS EXPRESS, Vol.22(22) : 27695-27706, 2014
1
-
Optics InfoBase Conference Papers, Vol.2022 : CMP15A_05, 2022
1
-
OPTICS LETTERS, Vol.37(4) : 623-625, 2012
1
-
OPTICS LETTERS, Vol.43(4) : 959-962, 2018
1
-
PATHOLOGY RESEARCH AND PRACTICE, Vol.194(1) : 3-9, 1998
1
-
PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol.26(8) : 780-788, 2015
1
-
Pediatric Allergy and Respiratory Disease (소아알레르기 호흡기학회지), Vol.10(2) : 153-164, 2000
1
-
PEDIATRIC PULMONOLOGY, Vol.48(3) : 221-228, 2013
1
-
PEPTIDES, Vol.32(3) : 568-572, 2011
1
-
Peripheral nerve damage is commonly observed in leprosy patients, but the pathogenic processes of nerve damage are still not well understood. In the present study, we produced monoclonal antibodies to protein components from human central nerve system (CNS) in an attempt to investigate the immunological mechanisms of nerve damage and to detect nerve antigen from sera in leprosy patients. Seven monoclonal antibodies (six were IgG1 and one was IgG2a in iso type) were produced; five antibodies were reactive with 38 kDa AND 43 kDa molecules from human CNS; other two antibodies were cross-reactive with human myelin basic protein and human muscle protein in ELISA. No antibody was reactive with rabbit peripheral nerve system protein. Although further
evaluations of these antibodies are required to know the specific binding site of CNS protein and the reactivity to other tissue protein, this study suggests that the monoclonal antibodies may be useful in studying the immunological mechanisms of nerve damage in leprosy.
1
-
PHARMACEUTICAL RESEARCH, Vol.22(10) : 1735-1746, 2005
1
-
PHARMACEUTICAL RESEARCH, Vol.37(3) : 50, 2020-02
1
-
PHARMACEUTICS, Vol.13(2) : 209, 2021-02
1
-
PHOTOCHEMISTRY AND PHOTOBIOLOGY, Vol.82(2) : 600-605, 2006
1
-
PLOS ONE, Vol.10(10) : e0139621, 2015
1
-
PLOS ONE, Vol.10(10) : e0141577, 2015
1
-
PLOS ONE, Vol.10(12) : e0145234, 2015
1
-
PLOS ONE, Vol.10(9) : e0139251, 2015
1
-
PLOS ONE, Vol.11(2) : e0148917, 2016
1
-
PLOS ONE, Vol.12(2) : e0171147, 2017
1
-
PLOS ONE, Vol.12(4) : e0175793, 2017
1
-
PLOS ONE, Vol.13(3) : e0193649, 2018
1
-
PLOS ONE, Vol.17(7) : e0272019, 2022-07
1
-
PLOS ONE, Vol.6(1) : e16105, 2011
1
-
PLOS ONE, Vol.8(11) : e78049, 2013
1
-
PLOS ONE, Vol.8(11) : e81560, 2013
1
-
PLOS ONE, Vol.8(2) : e58044, 2013
1
-
PLOS ONE, Vol.8(3) : e59646, 2013
1